Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions | MicrobiomeTrials← Back to trialsNCT06535490
Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-09-15Est. Completion: 2027-09-15
Enrollment target: 1,702 participants Locations- Clinique Paris-Bercy, Charenton-le-Pont, France
Other microbiome trials you might be interested in
Pancreatic Cancer
This investigation aims to demonstrate the feasibility of the lbFNA device for the first time in pancreatic cysts in hum…
Umeå, SwedenEst. completion Mar 2028
IPMNIPMN, Pancreatic
This is a multi-center randomized double-blind placebo controlled trial of patients with high-risk intraductal papillary…
Baltimore, United StatesEst. completion Jul 30, 2026
Recruiting
Pancreatic Cystic Lesion (PCL)
The aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopi…
Jinan, ChinaEst. completion Jun 30, 2028